News from sanofi pasteur msd A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

28 Sep, 2016, 08:00 BST Zostavax® Shingles Vaccine Wins UK Tender Renewal

Zostavax® shingles vaccine remains as part of the successful UK national immunisation programme for the next two years. Sanofi Pasteur MSD today...


07 Apr, 2016, 08:00 BST GARDASIL® 9: 2-dose Schedule Approved in Europe

The European Commission granted marketing authorization for a two-dose schedule in 9-14 year old girls and boys for GARDASIL®9, the 9-valent HPV...


22 Feb, 2016, 08:00 GMT Sanofi Pasteur MSD Welcomes European Initiatives to set Vaccination as Standard of Prevention in Seniors

Results of review-based evidence on the public healthvalue of vaccination for seniors in Europe presented at WAidid congress The first Biennial...


19 Feb, 2016, 08:00 GMT Vaxelis®, New Fully-liquid Paediatric Hexavalent Vaccine Approved in the European Union

This decision opens the way to making Vaxelis® available to infants and toddlers in European countries Sanofi Pasteur MSD announced today that the...


05 Nov, 2015, 16:26 GMT Human Papillomavirus Vaccines: The European Medicines Agency Safety Committee Concludes That Evidence Does Not Support That HPV Vaccines Cause CRPS or POTS

The European Medicine Agency's Pharmacovigilance Risk Assessment Committee (PRAC) concludes that there is no reason to change the way the vaccines...


17 Sep, 2015, 08:00 BST Sanofi Pasteur MSD Welcomes the Publication of a Special Issue on the Economic Value of Vaccination

A relevant and comprehensive approach on the benefits of vaccines on healthcare systems sustainability and economic growth Sanofi Pasteur MSD is...


29 Jun, 2015, 13:00 BST Sanofi Pasteur and Merck Vaccines Appoint David Khougazian as President of Sanofi Pasteur MSD

MSD, known as Merck in the United States and Canada (NYSE: MRK) and Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY),...


17 Jun, 2015, 08:00 BST Sanofi Pasteur MSD : GARDASIL®9: New HPV Vaccine Approved in the European Union

The European Commission grants marketing authorization for GARDASIL 9, the only 9-valent HPV vaccine Sanofi Pasteur MSD announced today that the...


20 Apr, 2015, 08:00 BST Sanofi Pasteur MSD Welcomes the 10 year Anniversary

European vaccine leader hosts events across the region to help raise awareness of immunization throughout life Sanofi Pasteur MSD welcomes the World...


27 Mar, 2015, 14:00 GMT GARDASIL® 9, New HPV Vaccine from Sanofi Pasteur MSD Granted Positive Opinion by European Committee for Medicinal Products for Human Use

European Committee for Medicinal Products for Human Use (CHMP) granted positive opinion for GARDASIL 9, the first 9-valent HPV vaccine Sanofi Pasteur ...


05 Mar, 2015, 08:00 GMT European Commission Grants "2+1 Immunization Schedule" for Hexyon® 6-in-1 Paediatric Vaccine

This decision opens the way to making Hexyon® available to more infants in European countries Sanofi Pasteur MSD announced today that the European...


05 Sep, 2014, 14:29 BST Gardasil®: The European Committee for Human Medicines Has Approved a Variation Stating its Long-Term Protection Data

Immunogenicity and Effectiveness data from the long-term follow-up of Gardasil studies demonstrate a sustained protection against HPV 6, 11, 16 and...


04 Sep, 2014, 16:45 BST Gardasil®: the European Committee for Human Medicines has Approved a Variation Stating its Long-term Protection Data

Immunogenicity and Effectiveness data from the long-term follow-up of Gardasil studies demonstrate a sustained protection against HPV 6, 11, 16 and...


18 Jun, 2014, 08:00 BST Gardasil® Approved in Europe for the Prevention of Anal Cancer

The European Commission granted a new indication for Gardasil®, for the prevention of anal cancer and anal precancerous lesions caused by specific...


30 Apr, 2014, 08:00 BST Gardasil®: CHMP Grants Positive Opinion for New Indication, for the Prevention of Anal Cancers and Anal Precancerous Lesions, in the European Union

European Committee for Medicinal Products for Human Use evaluated positively a new indication for the prevention of anal cancers and precancerous...


22 Apr, 2014, 08:00 BST Sanofi Pasteur MSD Welcomes European Immunization Week 2014

European vaccine leader hosts events across the region to help raise awareness of immunization throughout life Sanofi Pasteur MSD welcomes the World...


07 Apr, 2014, 08:00 BST Gardasil® Approved in the European Union for a 2-dose Schedule in Children Aged from 9 to 13 Years

 A new 2-dose regimen for Gardasil®, quadrivalent HPV vaccine, now available for adolescents Sanofi Pasteur MSD announced today that the European...


27 Feb, 2014, 08:00 GMT Gardasil®: New 2-dose Schedule Granted Positive CHMP Opinion for Europe's Leading HPV Vaccine

European Committee for Medicinal Products for Human Use evaluated positively a 2-dose schedule for Gardasil® in adolescents Sanofi Pasteur MSD...


18 Dec, 2013, 08:00 GMT French National Health Authority Recommends Routine Vaccination with Zostavax® to Protect Seniors Against Shingles

France becomes second European country after the UK to provide nation-wide recommendation for zoster vaccination. The French National High Council...


04 Nov, 2013, 12:30 GMT Pivotal Study of Investigational 9-Valent HPV Vaccine Demonstrates Additional Protection Against HPV-Related Disease

- New 9-valent HPV vaccine prevented 97% of cervical, vaginal and vulvar pre-cancers caused by five additional HPV types - Immunogenicity...


15 Oct, 2013, 08:00 BST Sanofi Pasteur MSD First Vaccine Company to Participate in Pilot for Rapid European Health Technology Assessment

Sanofi Pasteur MSD is the first vaccine company to have successfully participated in a pilot testing a new rapid relative effectiveness assessment of ...


11 Jul, 2013, 08:00 BST First Baby Vaccinated with Hexyon® in Europe

Germany first market in Europe to use innovative 6-in-1 paediatric vaccine Two month old baby Ben from Mönchengladbach, Germany, is the first infant...


22 Apr, 2013, 06:30 BST Hexyon[TM] 6-in-1 Paediatric Vaccine Approved in Europe

Hexyon is Europe's only fully liquid, ready-to-use hexavalent paediatric vaccine Sanofi Pasteur MSD, the joint venture between MSD and Sanofi Pasteur ...


11 Apr, 2013, 07:52 BST Sanofi Pasteur MSD Submits Quadrivalent Influenza Vaccine for European Licences

- Addition of fourth influenza virus strain aims to increase protection against influenza - Sanofi Pasteur MSD, the joint venture between MSD and...


22 Feb, 2013, 13:55 GMT European Medicines Agency Recommends Approval of Hexyon/Hexacima 6-in-1 Pediatric Vaccine

- Hexyon/Hexacima will be the only fully liquid, ready-to-use, 6-in-1 pediatric vaccine in Europe - Sanofi Pasteur, the vaccines division of Sanofi...